Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2012
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201793 Dermal micro-organs, methods and apparatuses for producing and using the same
08/09/2012US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells
08/09/2012US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same
08/09/2012US20120201786 Methods for the use of stem cells and stem cell factors in the treatment of skin conditions
08/09/2012US20120201769 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201753 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
08/09/2012US20120199152 Composition and method for treatment of hair loss with a combination of natural ingredients
08/09/2012CA2826262A1 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012CA2826232A1 Method of enhancing hair growth
08/09/2012CA2826073A1 Skin renewal enhancer
08/09/2012CA2825786A1 Externally-used drug for treating skin disorder and method for producing same
08/09/2012CA2810515A1 Hydrated n-fullerene amino acids, method for producing the latter, and pharmaceutical compositions on the basis thereof
08/09/2012CA2793515A1 Methods for treating diabetic foot ulcers
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484661A1 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same
08/08/2012EP2484357A1 Oral composition for reducing skin roughness
08/08/2012EP2484356A1 Oral composition for reducing wrinkle formation
08/08/2012EP2484355A1 Laminin-332 production stimulating composition
08/08/2012EP2484354A1 Antioxidant composition
08/08/2012EP2484353A1 Oral composition for alleviation of ultraviolet radiation-induced damage
08/08/2012EP2484340A1 Collagen production accelerating composition
08/08/2012EP2483300A1 Synthetic myostatin peptide antagonists
08/08/2012EP2482830A1 Extracts of phyllanthus niruri
08/08/2012EP2482816A1 Topical compositions of opioid antagonists and methods for treating skin conditions therewith
08/08/2012EP2482807A2 Compositions and methods of prophylaxis for contact dermatitis
08/08/2012EP2482796A1 Use of magnolol or honokiol as antibacterial, antimycotic, antiparasitic, or antiviral active ingredients
08/08/2012EP2482788A2 Topical tetracycline compositions
08/08/2012EP2482667A1 Leaven-based mixture
08/08/2012EP2205253B1 Composition and method inhibiting inflammation
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP2035004B1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
08/08/2012EP2004169B1 Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
08/08/2012EP1957092B1 Method for in vivo multiplication of hair
08/08/2012EP1515734B1 Honey-based skin care preparation
08/08/2012EP1462081B1 Production of ceramide emulsions
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012CN1439375B Dehydroepiandrosterone treating use and transfer system
08/08/2012CN102630160A Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents
08/08/2012CN102626512A Preparation method for traditional Chinese medicine lotion for treating malnutritional pustule on sole
08/08/2012CN102626500A Medicine for treating acne
08/08/2012CN102626473A Traditional Chinese medicine for treating traumatic injury, internal ulcer and external ulcer
08/08/2012CN102626470A Medicine for treating acne
08/08/2012CN102626469A Method for preparing high-purity tea polyphenol in centrifuging, extracting and separating mode
08/08/2012CN102626446A Ulcerative carbuncle toxin expelling pharmaceutical composition
08/08/2012CN102626441A Antipyrotic powder for external use
08/08/2012CN102626435A Pharmaceutical composition for treating burn and scald, hemorrhoids, exfoliative dermatitis or oral mucosa ulcer in cancer patient
08/08/2012CN102626414A Compound salicylic acid and clotrimazole aerosol
08/08/2012CN102626382A Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection
08/08/2012CN102626373A Agent for improving moisture content using Helipyrone A
08/08/2012CN102266499B Hair growth medicinal liquor and preparation process thereof
08/08/2012CN102266498B Hair-blackening medicinal liquor and preparation process thereof
08/08/2012CN102266441B Chinese medicinal ointment for treating burns and scalds
08/08/2012CN102178908B Preparation method of traditional Chinese medicine for treating over fatigue cold injury
08/08/2012CN102139111B Water-soluble matrix and application thereof in preparation of dithranol water-soluble preparations
08/08/2012CN102018667B Imidazoles antifungal skin wiping agent and preparation method thereof
08/08/2012CN101991588B Flake and pearl nucleus matching treating fluid for culturing Pinctada martensii pearl
08/08/2012CN101897693B Catechin compounds or application of plant extraction containing same and pharmaceutical composition
08/08/2012CN101869642B Chinese medicinal composition
08/08/2012CN101803531B China cryptoporus sinensis and solid cultural method and application thereof
08/08/2012CN101594859B Compositions comprising carnosic acid 12-methylether
08/08/2012CN101485791B Application of Ampelopsis grossedentata total flavone in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy
08/08/2012CN101468200B Beauty treatment health-care capsule produced from deep sea fish collagen and preparation thereof
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236924 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/07/2012US8236836 Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
08/07/2012US8236784 Composition comprising threitol phosphate and salts thereof
08/07/2012CA2683980C Topical composition comprising n-acetylaldosamines or n-acetylamino acids
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2438314C 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
08/02/2012WO2012103040A1 Paraben compositions
08/02/2012WO2012103039A1 Surfactant compositions
08/02/2012WO2012103037A1 Oil compositions
08/02/2012WO2012103035A1 Nanoparticle compositions
08/02/2012WO2012103011A1 Stable silver oxide formulations
08/02/2012WO2012102404A1 Topical antifungal agent
08/02/2012WO2012102364A1 Composition containing polyunsaturated fatty acid
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012101747A1 Tie2 ACTIVATOR, AGENT FOR MATURING, NORMALIZING OR STABILIZING BLOOD VESSELS, AGENT FOR STABILIZING LYMPHATIC VESSELS, PREPARATION FOR PREVENTING AND REDUCING WRINKLES, AND PREPARATION FOR REDUCING AND PREVENTING SWELLING
08/02/2012WO2012101746A1 Tie-2 activator, agent for maturation, normalization, or stabilization of blood vessels, lymph vessel stabilizing agent, wrinkle prevention/improvement agent, and edema improvement/prevention agent
08/02/2012WO2012101741A1 Tie-2 activator, agent for maturation, normalization, or stabilization of blood vessels, lymph vessel stabilizing agent, wrinkle prevention/improvement agent, and edema improvement/prevention agent
08/02/2012WO2012101605A1 Fgf receptor-activating 3-o-alkyl oligosaccharides, preparation thereof and therapeutic use thereof
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101032A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012100754A1 Chinese medicine composition for treating stab wounds, burns, and various traumas
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012WO2012061698A3 Compounds useful as modulators of trpm8
08/02/2012WO2012053014A3 Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
08/02/2012WO2012053013A3 Pharmaceutical compositions of anti-acne agents
08/02/2012WO2012053010A3 Method for treatment of acne using pharmaceutical compositions of clindamycin
08/02/2012WO2011113802A3 Imidazopyridine and purine compounds, compositions and methods of use
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196930 Topical formulation for diabetic foot ulcers
08/02/2012US20120196929 Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera
08/02/2012US20120196926 Benzopyran compounds as melanogenesis modifiers and uses thereof
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 1065